Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
Yesterday, I attended a meeting of the CSIS Commission on Strengthening America’s Health Security. The Commission issued an important report in Nov '19 - “Ending the Cycle of Crisis and Complacency in the U.S. Global Health Security.” https://buff.ly/2S1WK9J pic.twitter.com/ZBlfj6ZrRw
-
Deerfield’s Alex Karnal is absolutely right: adopting foreign price controls “prevents investors from being able to invest, and inventors from being able to invent.” https://buff.ly/37SAa92 pic.twitter.com/MUnFr9NEXd
-
In a must-watch video, Rachel King, co-founder and CEO of
#GlycoMimetics, urges President Trump to reject foreign price controls and ensure the U.S. continues to lead in innovation. https://buff.ly/2Ufoau4 pic.twitter.com/IqYwEZgdy3
-
New data from
@ConsumerReports show people are paying more at the pharmacy due to rising deductibles - an insurance tactic that shifts greater costs onto patients. This is exactly why we need a holistic solution that reins in Rx costs for PATIENTS. https://buff.ly/2uHQI4V pic.twitter.com/68sd9AHeOr
-
I told
@rileyraygriffin@business that our industry can’t talk its way out of the pricing debate.@IAmBiotech continues to advocate for OOP caps on drug costs under Medicare Part D. Let’s put politics aside and help seniors better afford the medicines they need.#JPM20pic.twitter.com/n57zBlki0G
-
During
#BiotechShowcase at#JPM20, I discussed BIO's commitment to capping out-of-pocket costs for patients in Part D. The truth is, short-sighed policies currently in front of Congress will stifle innovation and do little to help seniors better afford the medicines they need.pic.twitter.com/bcuHlQdiAz
-
As an health care system, we must work together so no patient ever goes without needed medicine because of high out-of-pocket costs and so no policies are enacted that would disincentivize investment that could help patients still waiting for a cure.
#JPM20pic.twitter.com/HeWUNFejTD
-
Honored to start my
#JPMWeek at the BayHelix Annual Meeting to discuss the importance of a stable U.S. regulatory environment to provide certainty to biotech investors so we can continue our progress on cross-border collaboration to cure disease.#JPM20pic.twitter.com/Lmh6DW0iGY
-
Happy 98th birthday to my beloved mother.pic.twitter.com/S6L21xFc09
-
So pleased that Virginia biochemist Camille Schrier, who grew up in my Newtown, PA neighborhood is the new Miss America showcasing biochemistry as her talent!pic.twitter.com/49mc3haFKy
-
Great interview with Jennifer Dent
@BIOVentures on efforts to ensure#cancer patients in#Africa have access to affordable and innovative treatments. https://buff.ly/2PIZoP9 pic.twitter.com/FnI5Gag7FA
-
#HR3 is the wrong approach for lowering drug costs. Let’s move past this extreme, partisan bill and get to work on a bipartisan, holistic solution. Watch more of my reaction to today’s vote on@SpeakerPelosi’s drug pricing plan.https://www.youtube.com/watch?v=4e7ti65iqQ0&feature=youtu.be … -
Welcomed business delegation from China's Hebei Province, including Vice Mayor of Hengshui City & Chairman of Hebei's Trade Promotion Council. We discussed the importance of pro-biotech policies to support the growth of the global biotech industry and cross-border opportunities.pic.twitter.com/91sJDAQeUd
-
One of my favorite events of the year, speaking with BIO's amazing state-based partners. Thank you for all you do each and every day!
@StateBiospic.twitter.com/1p17u7SFJt
-
Great to be down in Texas at the Capitol for the
#THBISummit, I spoke about Congress and the national political scene.pic.twitter.com/MK6CK1D6zY
-
I outlined two moral imperatives at the BIO Patient Health and Advocacy Summit: ensure no patient goes without their medicine because of their out-of-pocket costs and ensure access isn’t expanded at the expense of innovation for patients still waiting for a cure.
#BIOSummit19pic.twitter.com/dX3Nl1HNKb
-
Earlier this week I recorded the pilot episode of our Good Day BIO podcast focused on the growing public health menace of antibiotic resistance. I'll send out the link next week. Glyn Edwards and
@Summitplc are determined to conquer deadly superbugs. We must finance this work!pic.twitter.com/0gJiCUMNEG
-
Drug prices are NOT skyrocketing! As Congress debates
@SpeakerPelosi’s extreme Rx pricing plan that will stifle the development of innovative treatments, new data from@Altarum is more proof.#LowerDrugCosts http://bit.ly/33HWShk pic.twitter.com/fC2SHIGu42
-
Earlier today, I announced to my
@IAmBiotech team that we will begin the process of looking for a successor to lead this world-class organization, I announced that I will remain through 2020 and serve in an advisory capacity in 2021. Announcement here: https://buff.ly/35a3gj4 pic.twitter.com/dAJi5A5bHz
-
Great conversation today with
@SenMarkey on the incredible bioscience#innovation in Massachusetts, and the treatments and cures@IAmBiotech member companies are developing every day.pic.twitter.com/eEbQ6SLR4W
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.